Laboratory Medicine ›› 2022, Vol. 37 ›› Issue (2): 159-161.DOI: 10.3969/j.issn.1673-8640.2022.02.013
Previous Articles Next Articles
Received:
2020-08-14
Revised:
2021-03-06
Online:
2022-02-28
Published:
2022-03-15
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2022.02.013
项目 | 例数 | 年龄/岁 | 性别 | 住院时间/d | |
---|---|---|---|---|---|
男性/例 | 女性/例 | ||||
MP阳性组 | 113 | 5(3~6) | 69 | 44 | 10(8~12) |
MP阴性组 | 90 | 4(2~6) | 70 | 20 | 9(7~11) |
P值 | 0.357 5 | 0.010 9 | 0.009 7 |
项目 | 例数 | 年龄/岁 | 性别 | 住院时间/d | |
---|---|---|---|---|---|
男性/例 | 女性/例 | ||||
MP阳性组 | 113 | 5(3~6) | 69 | 44 | 10(8~12) |
MP阴性组 | 90 | 4(2~6) | 70 | 20 | 9(7~11) |
P值 | 0.357 5 | 0.010 9 | 0.009 7 |
组别 | 例数 | 发热/ [例(%)] | 扁桃体肿大伴白色渗出物或假膜覆盖/[例(%)] | 淋巴结肿大/[例(%)] | 眼睑浮肿/ [例(%)] | 皮疹/ [例(%)] | 肝脏肿大/ [例(%)] | 脾脏促大/ [例(%)] |
---|---|---|---|---|---|---|---|---|
MP阳性组 | 113 | 97(85.84) | 82(72.57) | 100(88.50) | 23(20.35) | 8(7.08) | 25(22.12) | 27(23.9) |
MP阴性组 | 90 | 76(84.44) | 50(55.56) | 74(82.22) | 13(14.44) | 9(10.00) | 20(22.22) | 24(26.67) |
P值 | 0.780 6 | 0.011 6 | 0.150 2 | 0.273 5 | 0.455 5 | 0.986 6 | 0.650 9 |
组别 | 例数 | 发热/ [例(%)] | 扁桃体肿大伴白色渗出物或假膜覆盖/[例(%)] | 淋巴结肿大/[例(%)] | 眼睑浮肿/ [例(%)] | 皮疹/ [例(%)] | 肝脏肿大/ [例(%)] | 脾脏促大/ [例(%)] |
---|---|---|---|---|---|---|---|---|
MP阳性组 | 113 | 97(85.84) | 82(72.57) | 100(88.50) | 23(20.35) | 8(7.08) | 25(22.12) | 27(23.9) |
MP阴性组 | 90 | 76(84.44) | 50(55.56) | 74(82.22) | 13(14.44) | 9(10.00) | 20(22.22) | 24(26.67) |
P值 | 0.780 6 | 0.011 6 | 0.150 2 | 0.273 5 | 0.455 5 | 0.986 6 | 0.650 9 |
组别 | 白细胞总数/(×109/L) | 淋巴细胞总数/ (×109/L) | 反应性淋巴细胞/% | EBV DNA/ (拷贝/mL) | 丙氨酸氨基转移酶/(U/L) |
---|---|---|---|---|---|
MP阳性组 | 14.91(11.47~19.34) | 10.02(7.307~12.57) | 17.50(12.00~31.50) | 323 000 (42 000~1 060 000) | 65.00(37.00~169.0) |
MP阴性组 | 13.08(9.605~18.29) | 7.330(4.751~11.54) | 13.00(10.75~28.00) | 165 000 (35 100~918 000) | 27.00(15.00~103.0) |
P值 | 0.100 0 | 0.028 0 | 0.100 2 | 0.525 8 | 0.002 9 |
组别 | 天门冬氨酸氨基转移酶/(U/L) | CD3/% | CD4/% | CD8/% | CD4+/CD8+比值 |
MP阳性组 | 66.00(47.00~123.0) | 90.50(89.75~93.00) | 11.00(8.000~14.00) | 73.00(67.00~82.00) | 0.160 0 (0.100 0~0.190 0) |
MP阴性组 | 47.000(32.00~79.00) | 88.00(87.50~90.00) | 14.00(10.50~19.00) | 67.00(57.25~73.50) | 0.220 0 (0.170 0~0.452 5) |
P值 | 0.000 6 | 0.040 4 | 0.007 8 | 0.023 0 | 0.004 8 |
组别 | 白细胞总数/(×109/L) | 淋巴细胞总数/ (×109/L) | 反应性淋巴细胞/% | EBV DNA/ (拷贝/mL) | 丙氨酸氨基转移酶/(U/L) |
---|---|---|---|---|---|
MP阳性组 | 14.91(11.47~19.34) | 10.02(7.307~12.57) | 17.50(12.00~31.50) | 323 000 (42 000~1 060 000) | 65.00(37.00~169.0) |
MP阴性组 | 13.08(9.605~18.29) | 7.330(4.751~11.54) | 13.00(10.75~28.00) | 165 000 (35 100~918 000) | 27.00(15.00~103.0) |
P值 | 0.100 0 | 0.028 0 | 0.100 2 | 0.525 8 | 0.002 9 |
组别 | 天门冬氨酸氨基转移酶/(U/L) | CD3/% | CD4/% | CD8/% | CD4+/CD8+比值 |
MP阳性组 | 66.00(47.00~123.0) | 90.50(89.75~93.00) | 11.00(8.000~14.00) | 73.00(67.00~82.00) | 0.160 0 (0.100 0~0.190 0) |
MP阴性组 | 47.000(32.00~79.00) | 88.00(87.50~90.00) | 14.00(10.50~19.00) | 67.00(57.25~73.50) | 0.220 0 (0.170 0~0.452 5) |
P值 | 0.000 6 | 0.040 4 | 0.007 8 | 0.023 0 | 0.004 8 |
[1] | 姚艳青, 崔红. 80例不同年龄儿童EB病毒相关性传染性单核细胞增多症的临床特点分析[J]. 中国医刊, 2017, 52(8):76-79. |
[2] | 谢正德, 刘春艳, 艾军红. EB病毒感染实验室诊断及临床应用专家共识[J]. 中华实验和临床病毒学杂志, 2018, 32(1):2-8. |
[3] | 汪东海, 陈建川, 田代印, 等. 儿童EB病毒致传染性单核细胞增多症并肺炎的危险因素[J]. 中华实用儿科临床杂志, 2019, 34(22):1698-1701. |
[4] | 胡继军, 凃星, 方静, 等. 武汉地区儿童肺炎支原体感染的流行病学分析[J]. 临床血液学杂志(输血与检验版), 2017, 30(6):937-939. |
[5] | 王敏华. 1 214例急性呼吸道感染住院患儿9种病原体检测分析[J]. 中国中西医结合儿科学, 2017, 9(2):175-177. |
[6] | XU Y, LI S, LIU J, et al. Impact of Epstein-Barr virus coinfection in Mycoplasma pneumoniae pneumonia[J]. Medicine(Baltimore), 2020, 99(16):e19792. |
[7] | 黄莉, 张新星, 顾文婧, 等. 肺炎支原体与EB病毒混合感染后肺炎的临床及实验室特征[J]. 临床儿科杂志, 2015, 33(8):690-693. |
[8] | 吉征喜, 孙祖银, 姚劲. 儿童EB病毒混合感染70例临床分析[J]. 国际儿科学杂志, 2018, 45(12):984-986. |
[9] | 闫超, 孙红妹, 赵汉青, 等. 北京地区10年间住院患儿肺炎支原体感染流行特征分析[J]. 中华实用儿科临床杂志, 2019, 34(16):1211-1214. |
[10] | 郭丽, 张善辉, 王平平. 儿童血清肺炎支原体感染情况调查[J]. 检验医学, 2012, 27(11):959-960. |
[11] | 黄姜伟, 韩方正. EB病毒性肝炎的研究进展[J]. 临床肝胆病杂志, 2018, 34(6):1333-1337. |
[12] | 张森, 李海英, 陈晓昕, 等. 儿童支原体肺炎肝功能损害临床分析[J]. 中国实用医刊, 2019, 46(3):20-23. |
[13] | 韩红满, 李四强. 传染性单核细胞增多症相关免疫学研究进展[J]. 医学综述, 2020, 26(3):443-447. |
[14] | 石铭, 蔡红阳, 王楠, 等. 患儿EB病毒感染与T淋巴细胞亚群变化的相关性[J]. 中华传染病杂志, 2016, 34(11):688-690. |
[15] | 毛艳, 柴建农, 王海红. 肺炎支原体感染儿童免疫功能、C-反应蛋白及D-二聚体的变化及临床意义[J]. 中国实用医刊, 2018, 45(4):32-35. |
[1] | ZHOU Ying, REN Yihui, LI Guangming. Serum miR-148a expression in children with autoimmune hepatitis and its correlation with inflammatory factors [J]. Laboratory Medicine, 2023, 38(12): 1130-1134. |
[2] | YAN An, GUAN Xuhuizi, YU Tian, MIAO Gang, ZHAO Yanyang. Identification of a new susceptibility gene variant EPB41L4A rs1455421289 in Chinese PTC patients by WES [J]. Laboratory Medicine, 2023, 38(11): 1009-1014. |
[3] | GAO Jianchao, WANG Sisi, ZHANG Zhisheng, ZHANG Jingli, LI Xiaoxia, MA Ke, FENG Zhilin, ZHOU Haifeng, WANG Zhanhai. Efficacy and prognosis evaluation of neo-adjuvant chemotherapy for breast cancer based on miR-206,miR-125 and miR-21 [J]. Laboratory Medicine, 2023, 38(11): 1062-1068. |
[4] | ZHU Qian, ZHU Lifang, MA Caiyun, YAO Jie. Relation of serum miR-140-5p and PGC-1α mRNA expression with vascular cognitive impairment in acute ischemic stroke patients [J]. Laboratory Medicine, 2023, 38(11): 1069-1074. |
[5] | HUANG Zhongqiang, DAI Di, HOU Tieying, LIN Faquan, LU Zhiming, LIU Xiaoqi, SHEN Minna, WU Jie, ZHANG Pingan, ZHOU Jun, XIAO Yanqun, WANG Hualiang. Multicenter performance evaluation of a 7-microRNA test kit [J]. Laboratory Medicine, 2023, 38(11): 1075-1081. |
[6] | XUE Yaze, HE Jin, TANG Shaojun. Roles of serum miR-150-5p and LTBP-2 determinations in evaluating the condition of acute cerebral infarction patients [J]. Laboratory Medicine, 2023, 38(11): 1082-1086. |
[7] | . [J]. Laboratory Medicine, 2023, 38(11): 1106-1108. |
[8] | GUO Mingri, LI Yuming, LI Yan, SUN Haibai. Difference in identification of non-tuberculous Mycobacterium between microarray chip and multiple homologous sequence [J]. Laboratory Medicine, 2023, 38(10): 909-914. |
[9] | ZHOU Jun, LI Liheng, ZHANG Min. Expressions of serum miR-24 and XIAP mRNA in serum of oral adenoid cystic carcinoma patients and relationship with prognosis [J]. Laboratory Medicine, 2023, 38(10): 930-935. |
[10] | LI Liangshan, ZHAO Hu, WANG Shiwen. Screening potential prognostic biomarkers of colorectal cancer based on weighted gene co-expression network analysis [J]. Laboratory Medicine, 2023, 38(9): 825-832. |
[11] | WANG Wei, ZHANG Zhixin, ZHANG Chuanbao, ZHOU Weiyan, WANG Zhiguo. Establishment of allowable total error,allowable imprecision and allowable bias for 22 endocrine analytes [J]. Laboratory Medicine, 2023, 38(8): 707-712. |
[12] | Clinical Laboratory Society of Chinese Association for Rehabilitation Medicine , Molecular Diagnostics Society of Shanghai Medical Association , Tumor Immunology Branch of Shanghai Society for Immunology , Yueyang Hospital of Integrated Traditional Chinese and Western Medicine of Shanghai University of Traditional Chinese Medicine , Shanghai Center for Clinical Laboratory, Clinical Laboratory Society of Chinese Association of Integrative Medicine , Clinical Laboratory Society of Shanghai Anticancer Association , Tumor Markers Society of Shanghai Anticancer Association . Expert consensus on the clinical application of AFP,AFP-L3% and DCP using GALAD and GALAD-like models in hepatocellular carcinoma [J]. Laboratory Medicine, 2023, 38(7): 607-623. |
[13] | ZHANG Xin, MA Lijuan. Role of cardiac markers in children [J]. Laboratory Medicine, 2023, 38(6): 505-509. |
[14] | LIU Ruili, LI Lanjun, JIA Minlei, WANG Yihui, HAO Weina. Correlation between tumor miR-7-5p and NOVA2 levels and clinical prognosis in cancer tissues of patients with gastric cancer [J]. Laboratory Medicine, 2023, 38(4): 325-329. |
[15] | WANG Xin, DENG Qian, WANG Juanjuan, CAI Wenjuan, GAO Jian, HAN Yanping, HU Kefei, CHEN Yuqing. Clinical characteristics and genetic analysis of Desbuquois dysplasia Kim type caused by CANT1 mutation [J]. Laboratory Medicine, 2023, 38(2): 130-136. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||